These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. T cell responses to alloantigens. IV. In vivo and in vitro studies of the abrogation of presensitization to major histocompatibility antigens. Burton RC; Fortin JL; Aversano RC; Russell PS Transplantation; 1982 Apr; 33(4):339-46. PubMed ID: 7041359 [TBL] [Abstract][Full Text] [Related]
26. Delayed secondary disease in mice after early or late therapy with anti-thymocyte serum. Kinnamon KE; Blackwell LH; Ledney GD Exp Hematol; 1973; 1(4):202-14. PubMed ID: 4154088 [No Abstract] [Full Text] [Related]
27. Removal of therapeutic anti-lymphocyte antibodies from human sera prior to anti-human leukocyte antibody testing. Bearden CM; Book BK; Sidner RA; Pescovitz MD J Immunol Methods; 2005 May; 300(1-2):192-9. PubMed ID: 15896799 [TBL] [Abstract][Full Text] [Related]
28. T lymphocytes that contribute to the immunoregulation of granuloma formation in chronic murine schistosomiasis. Colley DG J Immunol; 1981 Apr; 126(4):1465-8. PubMed ID: 6970776 [TBL] [Abstract][Full Text] [Related]
29. [Study of anti-macrophage serum and of its effect on antibody formation]. Liacopoulos-Briot M; Lambert F; Halpern B Ann Immunol (Paris); 1975 Apr; 126(3):249-65. PubMed ID: 1101798 [TBL] [Abstract][Full Text] [Related]
30. The effect of antilymphocytic antibody on the humoral immune response in different strains of mice. II. The response to sheep erythrocytes. Ghaffar A; James K Immunology; 1973 Mar; 24(3):455-65. PubMed ID: 4574575 [TBL] [Abstract][Full Text] [Related]
31. Differential effect of activated T amplifier cells on B cells responding to thymus-independent type 1 and type 2 antigens. Braley-Mullen H J Immunol; 1982 Aug; 129(2):484-9. PubMed ID: 6979573 [TBL] [Abstract][Full Text] [Related]
32. The influence of histocompatibility and antithymocyte serum on the ability of alloantigenic pretreatment to prolong the survival of mouse skin grafts. Cohen N; Latorre JA Folia Biol (Praha); 1975; 21(1):33-42. PubMed ID: 1091518 [TBL] [Abstract][Full Text] [Related]
33. Treatment of murine lupus with monoclonal anti-T cell antibody. Wofsy D; Ledbetter JA; Hendler PL; Seaman WE J Immunol; 1985 Feb; 134(2):852-7. PubMed ID: 3871218 [TBL] [Abstract][Full Text] [Related]
34. [Detection of a specific differentiation antigen of mouse T-cells activated by allogenic transplantation antigens]. Nesterenko VG; Gruner ShG Biull Eksp Biol Med; 1980 Jun; 89(6):708-10. PubMed ID: 6967339 [TBL] [Abstract][Full Text] [Related]
35. [The effect of anti-T sera on the natural killer activity of the splenocytes in C3HA mice at different times after the transplantation of hepatoma 22a cells]. Filatova NA; Malygin AM; Goriunova LB; Fel' VIa Tsitologiia; 1989 Oct; 31(10):1221-5. PubMed ID: 2533419 [TBL] [Abstract][Full Text] [Related]
36. Augmentation of the antimetastatic effect of anticoagulant drugs by immunostimulation in mice. Gorelik E Cancer Res; 1987 Feb; 47(3):809-15. PubMed ID: 3802083 [TBL] [Abstract][Full Text] [Related]
37. Prolongation of allograft survival in mice by administration of anti-Thy 1 serum. I. Mediation by in vivo activation of regulatory T cells. Gelfand MC; Paul WE J Immunol; 1975 Jul; 115(1):1-4. PubMed ID: 1097498 [TBL] [Abstract][Full Text] [Related]
38. Antilymphocytic antibodies and marrow transplantation. VII. Two of nine monoclonal anti-Thy-1 antibodies used for pretreatment of donor marrow suppressed graft-versus-host reactions without added complement. Thierfelder S; Cobbold S; Kummer U; Waldmann H; Schuh R Exp Hematol; 1985 Oct; 13(9):948-55. PubMed ID: 2864278 [TBL] [Abstract][Full Text] [Related]